• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing
The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine
Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments
Ibogaine's Momentum Is Real. So Is the Safety Gap Nobody's Solving.
Psychedelic Medicine Is Having an Identity Crisis — And That's a Good Thing
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won't Get You High
FDA's New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn't Fully Realized It Yet
Medical Psilocybin Act
PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field
Shop

New Study Gives Most Advanced View of the Brain on Psychedelics

Microdose NewsDesk by Microdose NewsDesk
March 21, 2023
in Science
Reading Time: 1 min read
A A
New Study Shows Ketamine’s Fast-Acting Effects on Depression

A new study looking at DMT effects on the brain has produced the most detailed view yet of psychedelics and DMT’s powerful potential.

The new study was published in the Proceedings of the National Academy of Sciences, led by Chris Timmermann, head of the DMT research group at Imperial College London. The research looked at 20 healthy volunteers receiving either a 20mg injection of DMT (a substantially-sized dose) or a placebo.

The patients were then monitored using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), with brain activity measured during before, during, and after the DMT session.

According to the researchers, the study gives us the most advanced picture to date of the human brain on psychedelics.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Our DMT Neuroimaging paper is out now in @PNASnews https://t.co/pcsSCaDKgR

TLDR: DMT is associated with a dysregulation of the developmentally/evolutionary recent cortex and linked to reduced alpha power, increased entropy, and 5-HT2AR density.

with @RCarhartHarris et al.
🧵 pic.twitter.com/zuCin3lbwb

— Chris Timmermann (@neurodelia) March 20, 2023

 

The readings show how normal structures in the brain cease their standard hierarchal modes, with increased connectivity between regions that handle imagination and other higher-level functions.

 

The TOP of the principal gradient has been linked to human-specific advancements: cortical expansion, abstract semantics, and longer temporal delays https://t.co/bPTJJfrRvv

Neurosynth analysis showed DMT overlapped with language, semantic, and task regions 9/n pic.twitter.com/TngrqFCCGJ

— Chris Timmermann (@neurodelia) March 20, 2023

 

See this Twitter thread

Order Lasix Online

from the study’s lead author for a detailed look at the findings. 

Click here for a look at the full study. 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: DMTscience
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Psychedelic Reform and Decrim Update

Decrim Update: Psychedelic Bills Move Forward in Several States

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.